India link in fresh US insider trading scam
- SC slams BCCI over Lodha report: Better fall in line, or we will make you fall in line
- SAARC Summit: Now, Bangladesh, Bhutan and Afghanistan say they won't be going to Islamabad
- To isolate Pak, India pulls out of Islamabad SAARC summit
- Global competitiveness index: India jumps 16 ranks for second time, now at 39
- Shimon Peres, last surviving link to Israel's founding fathers, dies at 93
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
- Power struggle within weakens Samajwadi Party already undergoing an identity crisis in UP
- Preventive detention is being routinised as an instrument of state repression
- The challenge of garbage is set to grow, solid waste management plans need to be implemented
- After Uri, a replay of a 2001 predicament
- Any response to Uri must factor in Pakistani state’s relationship with non-state actors
- It is assumed that Blacks will vote 93 per cent for Clinton, seven per cent for Trump